281 related articles for article (PubMed ID: 15304510)
21. The scaffold protein PDZK1 modulates expression and function of the organic anion transporting polypeptide 2B1.
Ferreira C; Hagen P; Stern M; Hussner J; Zimmermann U; Grube M; Meyer Zu Schwabedissen HE
Eur J Pharm Sci; 2018 Jul; 120():181-190. PubMed ID: 29752999
[TBL] [Abstract][Full Text] [Related]
22. The scaffold protein PDZK1 undergoes a head-to-tail intramolecular association that negatively regulates its interaction with EBP50.
LaLonde DP; Bretscher A
Biochemistry; 2009 Mar; 48(10):2261-71. PubMed ID: 19173579
[TBL] [Abstract][Full Text] [Related]
23. [Urate transporter and renal hypouricemia].
Enomoto A; Niwa T; Kanai Y; Endou H
Rinsho Byori; 2003 Sep; 51(9):892-7. PubMed ID: 14560659
[TBL] [Abstract][Full Text] [Related]
24. Omega-3 Polyunsaturated Fatty Acids Inhibit the Function of Human URAT1, a Renal Urate Re-Absorber.
Saito H; Toyoda Y; Takada T; Hirata H; Ota-Kontani A; Miyata H; Kobayashi N; Tsuchiya Y; Suzuki H
Nutrients; 2020 May; 12(6):. PubMed ID: 32486008
[TBL] [Abstract][Full Text] [Related]
25. Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2.
Sugiura T; Kato Y; Kubo Y; Tsuji A
Drug Metab Pharmacokinet; 2006 Oct; 21(5):375-83. PubMed ID: 17072090
[TBL] [Abstract][Full Text] [Related]
26. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone.
Iwanaga T; Kobayashi D; Hirayama M; Maeda T; Tamai I
Drug Metab Dispos; 2005 Dec; 33(12):1791-5. PubMed ID: 16135657
[TBL] [Abstract][Full Text] [Related]
27. Unique Binding Sites of Uricosuric Agent Dotinurad for Selective Inhibition of Renal Uric Acid Reabsorptive Transporter URAT1.
Fujita K; Isozumi N; Zhu Q; Matsubayashi M; Taniguchi T; Arakawa H; Shirasaka Y; Mori E; Tamai I
J Pharmacol Exp Ther; 2024 Jun; 390(1):99-107. PubMed ID: 38670801
[TBL] [Abstract][Full Text] [Related]
28. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.
Jutabha P; Anzai N; Kitamura K; Taniguchi A; Kaneko S; Yan K; Yamada H; Shimada H; Kimura T; Katada T; Fukutomi T; Tomita K; Urano W; Yamanaka H; Seki G; Fujita T; Moriyama Y; Yamada A; Uchida S; Wempe MF; Endou H; Sakurai H
J Biol Chem; 2010 Nov; 285(45):35123-32. PubMed ID: 20810651
[TBL] [Abstract][Full Text] [Related]
29. [Molecular biology of urate transporter].
Anzai N; Miyazaki H; Endou H
Seikagaku; 2004 Feb; 76(2):101-10. PubMed ID: 15049136
[No Abstract] [Full Text] [Related]
30. Function and localization of urate transporter 1 in mouse kidney.
Hosoyamada M; Ichida K; Enomoto A; Hosoya T; Endou H
J Am Soc Nephrol; 2004 Feb; 15(2):261-8. PubMed ID: 14747372
[TBL] [Abstract][Full Text] [Related]
31. Human vascular smooth muscle cells express a urate transporter.
Price KL; Sautin YY; Long DA; Zhang L; Miyazaki H; Mu W; Endou H; Johnson RJ
J Am Soc Nephrol; 2006 Jul; 17(7):1791-5. PubMed ID: 16775029
[TBL] [Abstract][Full Text] [Related]
32. Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate.
Nakanishi T; Ohya K; Shimada S; Anzai N; Tamai I
Nephrol Dial Transplant; 2013 Mar; 28(3):603-11. PubMed ID: 23291366
[TBL] [Abstract][Full Text] [Related]
33. Uric acid transport.
Rafey MA; Lipkowitz MS; Leal-Pinto E; Abramson RG
Curr Opin Nephrol Hypertens; 2003 Sep; 12(5):511-6. PubMed ID: 12920398
[TBL] [Abstract][Full Text] [Related]
34. PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2.
Kato Y; Sai Y; Yoshida K; Watanabe C; Hirata T; Tsuji A
Mol Pharmacol; 2005 Mar; 67(3):734-43. PubMed ID: 15523054
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor.
Taniguchi T; Ashizawa N; Matsumoto K; Saito R; Motoki K; Sakai M; Chikamatsu N; Hagihara C; Hashiba M; Iwanaga T
J Pharmacol Exp Ther; 2019 Oct; 371(1):162-170. PubMed ID: 31371478
[TBL] [Abstract][Full Text] [Related]
36. Human renal organic anion transporter 4 operates as an asymmetric urate transporter.
Hagos Y; Stein D; Ugele B; Burckhardt G; Bahn A
J Am Soc Nephrol; 2007 Feb; 18(2):430-9. PubMed ID: 17229912
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of high affinity inhibition of the human urate transporter URAT1.
Tan PK; Ostertag TM; Miner JN
Sci Rep; 2016 Oct; 6():34995. PubMed ID: 27713539
[TBL] [Abstract][Full Text] [Related]
38. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019).
Dong Y; Zhao T; Ai W; Zalloum WA; Kang D; Wu T; Liu X; Zhan P
Expert Opin Ther Pat; 2019 Nov; 29(11):871-879. PubMed ID: 31593642
[No Abstract] [Full Text] [Related]
39. Renal Reabsorptive Transport of Uric Acid Precursor Xanthine by URAT1 and GLUT9.
Arakawa H; Amezawa N; Kawakatsu Y; Tamai I
Biol Pharm Bull; 2020; 43(11):1792-1798. PubMed ID: 33132325
[TBL] [Abstract][Full Text] [Related]
40. Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes.
Zhang B; Duan M; Long B; Zhang B; Wang D; Zhang Y; Chen J; Huang X; Jiao Y; Zhu L; Zeng X
Mol Med Rep; 2019 Aug; 20(2):1645-1654. PubMed ID: 31257523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
